US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 257.190
  • +2.340+0.92%
Close Apr 29 16:00 ET
  • 256.140
  • -1.050-0.41%
Pre 08:24 ET
33.29BMarket Cap-117.98P/E (TTM)

About Alnylam Pharmaceuticals Company

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Company Profile

SymbolALNY
Company NameAlnylam Pharmaceuticals
Listing DateMay 27, 2004
Issue Price6.00
Founded2002
CEODr. Yvonne L Greenstreet, MB.Ch.B.
MarketNASDAQ
Employees2230
Fiscal Year Ends12-31
Address675 West Kendall Street,Henri A. Termeer Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-551-8200

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Yvonne L Greenstreet, MB.Ch.B.
  • Director and Chief Executive Officer
  • 11.49M
  • Tolga Tanguler
  • Chief Commercial Officer
  • 2.75M
  • Kevin Joseph Fitzgerald, PhD
  • Executive Vice President, Chief Scientific Officer and Head, Early Research and Early Development
  • 2.67M
  • Jeffrey V. Poulton
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.79M
  • Dr. Pushkal P. Garg, M.D.
  • Chief Medical Officer and Executive Vice President, Development and Medical Affairs
  • 2.92M
  • Amy W. Schulman
  • Chairman of the Board
  • 533.79K
  • Michael W. Bonney
  • Director
  • 458.79K
  • Dr. Phillip A. Sharp,PhD
  • Independent Director
  • 503.79K
  • Colleen F. Reitan
  • Independent Director
  • 491.29K
  • Peter N. Kellogg
  • Independent Director
  • 658.72K
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 478.79K
  • Dr. Olivier Raymond Brandicourt, M.D.
  • Independent Director
  • 481.29K
  • Dr. Margaret A. Hamburg, M.D.
  • Independent Director
  • 468.79K
  • Dr. Elliott Sigal, M.D.,PhD
  • Independent Director
  • 478.79K
  • Dr. Dennis A. Ausiello, M.D.
  • Independent Director
  • 478.79K
  • Dr. Carolyn R. Bertozzi, PhD
  • Independent Director
  • 438.79K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now